Clinical Trial Update: A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for GZR18 injection in Chinese adults with Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR18

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: COMPLETED